Tackling the Various Classes of Nano-therapeutics Employed in Topical Therapy of Psoriasis

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2020 May 13

PMID 32393082

Citations 17

Authors

Salma A Fereig

Ghada M El-Zaafarany

Mona G Arafa

Mona M A Abdel-Mottaleb

Affiliations

Soon will be listed here.

Abstract

Psoriasis is a dermatological chronic skin condition with underlying autoimmune etiology. It deeply affects patients' quality of life. Therefore, it was an interesting target for researchers throughout the past years. Conventionally, the treatment options include anti-inflammatory agents, immune suppressants, biologic treatment, and phototherapy. Nanotechnology offers promising characteristics that allow for tailoring a drug carrier to achieve dermal targeting, improved efficacy and minimize undesirable effects. Being the safest route, the first line of treatment and a targeted approach, we solely discussed the use of the topical route, combined with advanced drug delivery systems for the management of psoriasis in this article. Advanced systems include polymeric, metallic, lipidic and hybrid nanocarriers incorporating different active agents. All formerly mentioned types of drug delivery systems were investigated through the past decades for the purpose of topical application on psoriatic plaques. Scientists' efforts are promising to reach an optimized formula with a convenient dosage form to improve efficacy, safety, and compliance for the treatment of psoriasis. Accordingly, it will offer a better quality of life for patients.

Citing Articles

Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy.

Longobardi G, Moore T, Conte C, Ungaro F, Satchi-Fainaro R, Quaglia F Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(5):e1990.

PMID: 39217459 PMC: 11670051. DOI: 10.1002/wnan.1990.

Exploring the Therapeutic Potential of Natural Compounds in Psoriasis and Their Inclusion in Nanotechnological Systems.

Burlec A, Hancianu M, Ivanescu B, Macovei I, Corciova A Antioxidants (Basel). 2024; 13(8).

PMID: 39199158 PMC: 11352172. DOI: 10.3390/antiox13080912.

Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.

An P, Zhao Q, Hao S, Wang X, Tian J, Ma Z Int J Nanomedicine. 2024; 19:7631-7671.

PMID: 39099792 PMC: 11296365. DOI: 10.2147/IJN.S461514.

Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties.

R Telange D, Mahajan N, Mandale T, More S, Warokar A Bioprocess Biosyst Eng. 2024; 47(8):1409-1431.

PMID: 38995363 DOI: 10.1007/s00449-024-03058-5.

Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles.

Bodnar K, Feher P, Ujhelyi Z, Bacskay I, Jozsa L Pharmaceutics. 2024; 16(4).

PMID: 38675110 PMC: 11054466. DOI: 10.3390/pharmaceutics16040449.

References

Rahman M, Beg S, Akhter S . Conventional formulations, Challenges, and Nanomedicines in Infective and Non-Infective Skin Diseases Therapy. Recent Pat Antiinfect Drug Discov. 2019; 14(1):5-6. DOI: 10.2174/1574891X14666190809115503. View

Jain A, Doppalapudi S, Domb A, Khan W . Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. J Control Release. 2016; 243:132-145. DOI: 10.1016/j.jconrel.2016.10.004. View

Pivetta T, Simoes S, Araujo M, Carvalho T, Arruda C, Marcato P . Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Colloids Surf B Biointerfaces. 2018; 164:281-290. DOI: 10.1016/j.colsurfb.2018.01.053. View

Lapteva M, Santer V, Mondon K, Patmanidis I, Chiriano G, Scapozza L . Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. J Control Release. 2014; 196:9-18. DOI: 10.1016/j.jconrel.2014.09.021. View

Niska K, Zielinska E, Radomski M, Inkielewicz-Stepniak I . Metal nanoparticles in dermatology and cosmetology: Interactions with human skin cells. Chem Biol Interact. 2017; 295:38-51. DOI: 10.1016/j.cbi.2017.06.018. View

Rosado C, Silva C, Reis C . Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment. Pharm Dev Technol. 2012; 18(3):710-8. DOI: 10.3109/10837450.2012.712537. View

Pinto M, Moura C, Nunes C, Segundo M, Costa Lima S, Reis S . A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm. 2014; 477(1-2):519-26. DOI: 10.1016/j.ijpharm.2014.10.067. View

Rahman M, Kumar V, Beg S, Sharma G, Katare O, Anwar F . Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artif Cells Nanomed Biotechnol. 2016; 44(7):1597-608. DOI: 10.3109/21691401.2015.1129617. View

Alfurhood J, Sun H, Kabb C, Tucker B, Matthews J, Luesch H . Poly(-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers. Polym Chem. 2017; 8(34):4983-4987. PMC: 5612619. DOI: 10.1039/C7PY00196G. View

10.

Mukherjee S, Ray S, Thakur R . Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2010; 71(4):349-58. PMC: 2865805. DOI: 10.4103/0250-474X.57282. View

11.

Kaur A, Katiyar S, Kushwah V, Jain S . Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. Nanomedicine. 2017; 13(4):1473-1482. DOI: 10.1016/j.nano.2017.02.009. View

12.

Zhou X, Chen Z . Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharm Res. 2015; 38(12):2193-200. DOI: 10.1007/s12272-015-0630-7. View

13.

Bakshi H, Nagpal M, Singh M, Dhingra G, Aggarwal G . Treatment of Psoriasis: A Comprehensive Review of Entire Therapies. Curr Drug Saf. 2020; 15(2):82-104. DOI: 10.2174/1574886315666200128095958. View

14.

Rapalli V, Singhvi G, Dubey S, Gupta G, Chellappan D, Dua K . Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed Pharmacother. 2018; 106:707-713. DOI: 10.1016/j.biopha.2018.06.136. View

15.

Hussain T, Tan B, Yin Y, Blachier F, Tossou M, Rahu N . Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?. Oxid Med Cell Longev. 2016; 2016:7432797. PMC: 5055983. DOI: 10.1155/2016/7432797. View

16.

Sticherling M . Psoriasis and autoimmunity. Autoimmun Rev. 2016; 15(12):1167-1170. DOI: 10.1016/j.autrev.2016.09.004. View

17.

Jaiswal M, Dudhe R, Sharma P . Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2017; 5(2):123-127. PMC: 4362737. DOI: 10.1007/s13205-014-0214-0. View

18.

Wang M, Lai X, Shao L, Li L . Evaluation of immunoresponses and cytotoxicity from skin exposure to metallic nanoparticles. Int J Nanomedicine. 2018; 13:4445-4459. PMC: 6078075. DOI: 10.2147/IJN.S170745. View

19.

Arafa M, Mousa H, Afifi N . Preparation of PLGA-chitosan based nanocarriers for enhancing antibacterial effect of ciprofloxacin in root canal infection. Drug Deliv. 2019; 27(1):26-39. PMC: 6968620. DOI: 10.1080/10717544.2019.1701140. View

20.

Senyigit T, Sonvico F, Barbieri S, Ozer O, Santi P, Colombo P . Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release. 2009; 142(3):368-73. DOI: 10.1016/j.jconrel.2009.11.013. View